A Phase III non-inferiority clinical trial of 4 strains seasonal flu vaccine.
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 10 May 2017 Status changed from recruiting to completed, according to an Adimmune Corporation media release.
- 23 Nov 2016 According to an Adimmune Corporation media release, company begin the process for a Biologics License Application (BLA) in 2017.
- 09 Nov 2016 New trial record